TFEB’s involvement includes lipid catabolism and it’s a clear potential therapeutic target mediating cellular clearance in a variety of diseases, including rare lysosomal storage diseases and more prevalent ones such as Parkinson’s and Alzheimer’s (Napolitano and Ballabio, 2016). Here, TFEB is linked to lysosomal storage disease.